How new drugs may change the standard of care for CLL
GCLLSG trial results to be presented at the 2016 ASH Annual Meeting
Common side-effects of BTK inhibitors (ibrutinib and acalabrutinib) in the treatment of CLL
The importance of diagnostic testing in CLL
Diagnosis and Initial Treatment of CLL
Peter Hillmen et al.